Original Query: ALL
Previous Study | Return to List | Next Study

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01476449
Recruitment Status : Completed
First Posted : November 22, 2011
Last Update Posted : October 5, 2016
Genentech, Inc.
Information provided by (Responsible Party):
Retina Vitreous Associates of Florida

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2016
  Study Completion Date : September 2016